Related Experiment Video
Updated: May 2, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Combined Ketamine and Midazolam Versus Midazolam Alone for Initial Treatment of Pediatric Generalized Convulsive
Amr A Othman1, Abdelrahim A Sadek1, Esraa A Ahmed2
1Neuropsychiatry Unit, Department of Pediatrics, Faculty of Medicine, Sohag University, Sohag, Egypt.
Insights
Adding ketamine to midazolam significantly improved seizure cessation in children with generalized convulsive status epilepticus (GCSE). This combination therapy offers a promising alternative for first-line treatment of pediatric GCSE.
Area of Science:
- Pediatric Neurology
- Emergency Medicine
- Clinical Pharmacology
Background:
- Generalized convulsive status epilepticus (GCSE) in children often proves refractory to initial benzodiazepine treatment.
- Approximately one-third of pediatric GCSE cases require alternative or additional therapies beyond standard benzodiazepines.
- Investigating novel therapeutic combinations is crucial for improving outcomes in pediatric GCSE.
Purpose of the Study:
- To evaluate the efficacy of ketamine as an adjunct to midazolam for the first-line management of pediatric GCSE.
- To compare the seizure cessation rates and safety profiles of ketamine-midazolam versus midazolam-placebo in pediatric GCSE.
Main Methods:
- A randomized controlled trial involving 144 pediatric patients (6 months to 16 years) diagnosed with GCSE.
- Patients were randomized to receive either ketamine plus midazolam (Ket-Mid group) or placebo plus midazolam (Pla-Mid group).
- Primary outcome was seizure cessation at 5 minutes; secondary outcomes included seizure control at later timepoints and adverse events.
Main Results:
- The ketamine-midazolam group achieved significantly higher seizure cessation rates at 5 minutes (76% vs 21%) compared to the placebo-midazolam group.
- The Ket-Mid group demonstrated superior seizure control at 15, 35, and 55 minutes, with reduced need for repeat midazolam boluses and endotracheal intubation.
- While statistically significant, differences in other measured outcomes between the groups were not substantial.
Conclusions:
- The combination of ketamine and midazolam appears more effective than midazolam alone for the initial treatment of pediatric GCSE.
- Further research is warranted to confirm these findings and establish the definitive role of ketamine in pediatric GCSE management.
- This study suggests a potential improvement in first-line treatment strategies for pediatric status epilepticus.
Background:
Approximately one third of children with generalized convulsive status epilepticus (GCSE) are not controlled by initial benzodiazepine therapy. We investigated the efficacy of adding ketamine to midazolam for first-line treatment of pediatric GCSE.
Methods:
This randomized controlled trial included 144 children with GCSE aged between six months and 16 years, who were equally randomized to receive ketamine plus midazolam (Ket-Mid group) or placebo plus midazolam (Pla-Mid group). Primary outcome was cessation of clinical seizures at five-minute study timepoint. Secondary outcomes were the need for a second midazolam bolus; cessation of clinical seizures at 15-, 35-, and 55-minute timepoints; 24-hour seizure control; and adverse effects.
Results:
Cessation of clinical seizures at five-minute occurred in 76% of children in the Ket-Mid group compared with 21% in the Pla-Mid group (risk ratio [RR] 3.7; 95% confidence interval [CI] 2.3-5.9; P < 0.001). Compared with the Pla-Mid group, the Ket-Mid group had higher percentages of seizure cessation at 15-minute (76.4% vs 23.6%; RR, 3.2; 95% CI, 2.1-5.0), 35-minute (83.3% vs 45.8%; RR, 1.8; 95% CI, 1.4-2.4), and 55-minute (88.9% vs 72.2%; RR, 1.2; 95% CI, 1.04-1.45) study timepoints as well as lower percentages of repeating midazolam (23.6% vs 79.2%; RR, 0.3; 95% CI, 0.19-0.46) and endotracheal intubation (4.2% vs 20.8%; RR, 0.2; 95% CI, 0.06-0.66). Both groups showed no significant differences in other outcome measures.
Conclusions:
Ketamine-midazolam combination may be more effective than midazolam alone for the initial treatment of pediatric GCSE, but this should be confirmed in future research.
More Related Videos
04:51Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Drug Delivery: Enteral Route